3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 3
2
Phase EARLY_PHASE1
1
Phase 2/3
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
186
INDUSTRY
148
NIH
97
NETWORK
8
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Melanoma
6
Lymphoma, B-Cell
5
Uveal Melanoma
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Recurrence
3
Polycystic Ovary Syndrome
3
Neoplasms, Plasma Cell
3
Multiple Myeloma
3
Hematologic Neoplasms
3
Glioblastoma
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Follicular
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Head and Neck Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Interventions
durvalumab
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
OTHER_GOV
×
Lymphoma, Large B-Cell, Diffuse
×
Clear all
NCT03610061
2024-04-12
RaDD
Austin Health
Phase 1
Completed
34 enrolled